Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 254,882 | 271,772 | 257,366 | 270,727 | 291,415 |
| Receivables | 11,461 | 10,954 | 9,510 | 10,150 | 11,842 |
| Other current assets | 1,875 | 3,365 | 6,319 | 6,060 | 2,073 |
| TOTAL | $271,840 | $289,708 | $276,527 | $287,831 | $306,891 |
| Non-Current Assets | |||||
| PPE Net | 22 | 24 | 10 | 11 | 12 |
| Intangibles | 545 | 545 | 545 | 545 | 545 |
| Other Non-Current Assets | 17,505 | 17,847 | 15,388 | 15,542 | 15,698 |
| TOTAL | $18,072 | $18,416 | $15,943 | $16,098 | $16,255 |
| Total Assets | $289,912 | $308,124 | $292,470 | $303,929 | $323,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,651 | 3,492 | 823 | 2,493 | 7,237 |
| Accrued Expenses | 8,269 | 3,585 | 7,397 | 7,467 | 17,703 |
| Other current liabilities | 736 | 435 | 416 | 444 | 509 |
| TOTAL | $14,774 | $8,692 | $9,012 | $10,949 | $26,523 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,546 | 48,374 | 19,905 | 19,857 | 19,809 |
| Other Non-Current Liabilities | 0 | 1,775 | 0 | 0 | 0 |
| TOTAL | $50,150 | $50,149 | $19,925 | $19,887 | $19,874 |
| Total Liabilities | $64,924 | $58,841 | $28,937 | $30,836 | $46,397 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,082 | 80,816 | 79,940 | 79,484 | 79,458 |
| Common Shares | 42,771 | 42,771 | 41,753 | 41,753 | 41,753 |
| Retained earnings | -414,397 | -388,433 | -374,053 | -359,143 | -350,110 |
| Other shareholders' equity | -4,883 | -4,118 | -4,347 | -4,576 | -4,809 |
| TOTAL | $224,988 | $249,283 | $263,533 | $273,093 | $276,749 |
| Total Liabilities And Equity | $289,912 | $308,124 | $292,470 | $303,929 | $323,146 |